Located adjacent to ASU’s downtown campus, the Phoenix Biomedical Campus (PBC) Innovation Center expands the downtown biomedical corridor to the northern edges of the urban core. Designed to integrate research, entrepreneurial activity, and corporate engagement, the building offers opportunities for meaningful collaboration with the building tenants and community.Continue reading
Author Archive: AZBio
UArizona Health Sciences, Cancer Center Launching Arizona Clinical Trials Network
Arizona residents, including underserved and underrepresented populations, will have better access to cutting-edge cancer therapies as the UArizona Cancer Center offers its clinical trials at locations across the state.Continue reading
AZBio Health Innovation Spotlight Public Information Campaign Kicks Off with Vaccine Information
The Sonoran Living Health Innovation Spotlight Public Information Campaign is designed to tackle one of our bioscience industry’s greatest challenges, the “Who Knew” Effect.
Arizona life science innovators are working to discover, develop, and deliver life saving and life changing innovations.
In 2021, AZBio is pleased to partner with ABC15 and CW61 to share quick Sonoran Living Health Innovation Spotlights during the morning and evening news hours along with longer segments on Sonoran Living periodically during 2021 to help our community learn more about the work of Arizona’s healthcare innovators. Each segment touches on a public health challenge or opportunity and spotlights an Arizona life science company’s work to create a solution.
Investigational AstraZeneca vaccine prevents COVID-19
Results from a large clinical trial in the United States and South America indicate that AstraZeneca’s COVID-19 vaccine, AZD1222, is well-tolerated and protects against symptomatic COVID-19 disease, including severe disease or hospitalization. The independent Data and Safety Monitoring Board (DSMB) overseeing the trial identified no safety concerns related to the vaccine. The United Kingdom-based global biopharmaceutical company AstraZeneca developed the vaccine and led the trial as regulatory sponsor.Continue reading
Novel Coronavirus Circulated Undetected Months Before First COVID-19 Cases in Wuhan
A new study dates emergence of the virus that causes COVID-19 to as early as October 2019. Simulations also suggest that in most cases, zoonotic viruses die out naturally before causing a pandemic.Continue reading
NAU bioengineer partners with industry expert to launch successful spin-off commercializing mobility technologies
Company’s first prototype product—a lightweight, wearable robotic ankle assist device—is designed to grow with the patient, an innovation that meets a specific market needContinue reading
SenesTech Announces Successful Completion of a Long Term Agricultural Deployment of ContraPest®
PHOENIX, March 18, 2021 /PRNewswire/ — SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced the conclusion of agricultural deployments of ContraPest® with demonstrated, sustained success in reducing rat populations and improving operating economies in poultry settings.Continue reading
UArizona College of Pharmacy Receives Gift to Support Students in Dual Pharmacy-Nursing Degree Program
The University of Arizona College of Pharmacy has been awarded a $1.4 million grant from the Flinn Foundation.Continue reading
Virtual Student Industry Networking Event Connects Trainees with Arizona Industry Bioscience Leaders for Thirteenth Year
The annual Student Industry Networking Event is co-hosted by the BIO5 Institute and the Bioindustry Organization of Southern Arizona (BIOSA).
New study highlights first infection of human cells during spaceflight
Astronauts face many challenges to their health, due to the exceptional conditions of spaceflight. Among these are a variety of infectious microbes that can attack their suppressed immune systems.Continue reading